XNAS · AXSM
-6.07% · -$15.10 · Vol 804.7K
Market closed · last close 4:00 PM ET · price as of 17:31:02 ET
Axsome Therapeutics, Inc

Axsome Therapeutics, Inc

PHARMACEUTICAL PREPARATIONS
$233.85
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
HISTORY WINDOW BUILDING
AI Analysis
Sovereign

Why is AXSM moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for AXSM are being assembled.
About Axsome Therapeutics, Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2015
Employees
925
Country
US

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$248.32
Day high
$249.11
Day low
$230.14
Previous close
$248.95
52W high
$249.11
-6.13% from high
52W low
$230.14
20% of range
Market cap
$12.8B
EPS
$-4.3900
Shares out
51.5M
Volume
804.7K
VWAP
$234.61
Price history computed in-house
SMA 50 $233.82 · above
SMA 200 $233.82 · above
52W position 20%
Veridion warehouse edge

Warehouse intelligence for AXSM.

Veridion Score
53
0: 121: 412: 693: 464: 825: 70
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

AXSM insider activity

Axsome Therapeutics, Inc

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for AXSM.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

AXSM contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AXSM in this window.
Lobbying spend

AXSM lobbying filings, year to date.

Registered lobbying filings matched to Axsome Therapeutics, Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AXSM in this window.
Latest news · AXSM
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for AXSM.
Options
Sovereign unlock shows live options positioning for AXSM.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.